As important as both corporate and personal branding have been across most industries in the last half-century, they’ve been something of an afterthought in life sciences, where the focus is always on the product over than the company or the people.
That may have something to do with the public’s famous distrust of the industry in recent years. But as Vanguard Principal Ken Banta notes in this conversation with branding expert and Straightline CEO Michael Watras, the pandemic and the race for vaccines has created an opening for something different.
